【港股异动 | 再鼎医药(09688.HK)再涨超10% 三季度产品收入1.076亿美元 Zoci全球临床研发取得新进展】智通财经APP获悉,再鼎医药(09688.HK)再涨超10%。截至发稿,涨10.02%,报20.2港元,成交额2403.96万港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.